June 16, 2021 at 13:24 #2633
Hi Lori. Thanks for the info. Yes, enoxaparin biosimilars were just approved and will hit the market shortly:
- Inclunox (Sandoz Canada)
- Noromby (Juno Pharmaceuticals Corp)
- Redesca (Shenzhen Techdow Pharmaceutical)
They could result in significant cost savings. I suspect there are not any centres using enoxaparin for hemo though.